Treatment of Recurrent and Advance Colorectal Cancer (TRACC): A prospective multi-site registry
Recruiting
- Conditions
- Advanced Colorectal Cancer
- Registration Number
- ACTRN12618000404224
- Lead Sponsor
- Biogrid
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie treatment resistance in ACTRN12618000404224 advanced colorectal cancer registry?
How does TRACC registry data compare with standard-of-care outcomes for metastatic colorectal cancer patients?
Which biomarkers are associated with prognosis in ACTRN12618000404224 recurrent colorectal cancer cohort?
What adverse events are reported in ACTRN12618000404224 and how are they managed in clinical practice?
Are there novel combination therapies being explored alongside TRACC for RAS/RAF mutant colorectal cancer?